WallStreetZen

NASDAQ: AZN
Astrazeneca Plc Stock Forecast, Predictions & Price Target

Analyst price target for AZN

Based on 1 analysts offering 12 month price targets for Astrazeneca Plc.
Min Forecast
$73.00+18.18%
Avg Forecast
$73.00+18.18%
Max Forecast
$73.00+18.18%

Should I buy or sell AZN stock?

Based on 5 analysts offering ratings for Astrazeneca Plc.
Strong Buy
Strong Buy
3 analysts 60%
Buy
1 analysts 20%
Hold
1 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

AZN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
SVB Leerink
Bottom 2%
2
BuyMaintains$73.00+18.18%2021-09-27
Argus Research
Top 30%
71
HoldDowngradesN/AN/A2021-04-12
Jefferies
Bottom 19%
19
Strong BuyUpgradesN/AN/A2021-03-16
UBS
Bottom 45%
45
Strong BuyUpgradesN/AN/A2021-02-25
Deutsche Bank
Top 45%
56
Strong BuyInitiates Coverage OnN/AN/A2021-01-15
Anonymous
Morgan Stanley
Strong BuyUpgradesN/AN/A2020-12-07

1 of 1

Forecast return on equity

Is AZN forecast to generate an efficient return?
Company
38.75%
Industry
71.43%
Market
16.16%
AZN's Return on Equity is forecast to be high in 3 years (38.75%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is AZN forecast to generate an efficient return on assets?
Company
8.25%
Industry
16.43%
AZN is forecast to generate lower Return on Assets (8.25%) than the US Drug Manufacturers - General industry average (16.43%)
Forecast

AZN earnings per share forecast

What is AZN's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$2.64+83.33%
Avg 2 year Forecast
$3.54+145.83%
Avg 3 year Forecast
$4.15+188.19%
AZN's earnings are forecast to grow at an exceptional rate of 43.1% per year
Forecast

AZN revenue forecast

What is AZN's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$36.2B+22.59%
Avg 2 year Forecast
$43.4B+46.93%
Avg 3 year Forecast
$48.0B+62.57%
AZN's revenue is forecast to grow at a rate of 17.58% per year, which is not exceptional
Forecast

AZN earnings growth forecast

How is AZN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
43.1%
Industry
22.4%
Market
17.18%
AZN's earnings are forecast to grow faster (43.1% per year) than the US Drug Manufacturers - General industry average (22.4%)
Forecast
AZN's earnings are forecast to grow faster (43.1% per year) than the US market average (17.18%)
Forecast
AZN's earnings are forecast to grow faster (43.1% per year) than the risk-free savings rate (1.5%)
Forecast

AZN revenue growth forecast

How is AZN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
17.58%
Industry
4.51%
Market
11.34%
AZN's revenues are forecast to grow faster (17.58% per year) than the US Drug Manufacturers - General industry average (4.51%)
Forecast
AZN's revenues are forecast to grow faster (17.58% per year) than the US market average (11.34%)
Forecast

Astrazeneca Stock Forecast FAQ

Is Astrazeneca Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: AZN) stock is to Strong Buy AZN stock.

Out of 5 analysts, 3 (60%) are recommending AZN as a Strong Buy, 1 (20%) are recommending AZN as a Buy, 1 (20%) are recommending AZN as a Hold, 0 (0%) are recommending AZN as a Sell, and 0 (0%) are recommending AZN as a Strong Sell.

What is AZN's earnings growth forecast for 2021-2023?

(NASDAQ: AZN) Astrazeneca's forecast annual earnings growth rate of 43.1% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 22.4%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 17.18%.

Astrazeneca's earnings in 2021 is $3,768,000,000.On average, 4 Wall Street analysts forecast AZN's earnings for 2021 to be $3,463,680,000, with the lowest AZN earnings forecast at $3,371,840,000, and the highest AZN earnings forecast at $3,516,160,000. On average, 5 Wall Street analysts forecast AZN's earnings for 2022 to be $4,644,480,000, with the lowest AZN earnings forecast at $4,250,880,000, and the highest AZN earnings forecast at $5,011,840,000.

In 2023, AZN is forecast to generate $5,444,800,000 in earnings, with the lowest earnings forecast at $4,985,600,000 and the highest earnings forecast at $5,904,000,000.

What is AZN's revenue growth forecast for 2021-2023?

(NASDAQ: AZN) Astrazeneca's forecast annual revenue growth rate of 17.58% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 4.51%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 11.34%.

Astrazeneca's revenue in 2021 is $29,528,000,000.On average, 3 Wall Street analysts forecast AZN's revenue for 2021 to be $47,491,041,280,000, with the lowest AZN revenue forecast at $46,563,299,840,000, and the highest AZN revenue forecast at $48,062,496,000,000. On average, 3 Wall Street analysts forecast AZN's revenue for 2022 to be $56,920,957,312,000, with the lowest AZN revenue forecast at $55,787,552,000,000, and the highest AZN revenue forecast at $58,680,512,000,000.

In 2023, AZN is forecast to generate $62,979,576,512,000 in revenue, with the lowest revenue forecast at $62,066,784,000,000 and the highest revenue forecast at $64,780,000,000,000.

What is AZN's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: AZN) forecast ROA is 8.25%, which is lower than the forecast US Drug Manufacturers - General industry average of 16.43%.

What is AZN's Price Target?

According to 1 Wall Street analysts that have issued a 1 year AZN price target, the average AZN price target is $73.00, with the highest AZN stock price forecast at $73.00 and the lowest AZN stock price forecast at $73.00.

On average, Wall Street analysts predict that Astrazeneca's share price could stay at $73.00 by Sep 27, 2022. The average Astrazeneca stock price prediction forecasts a potential downside of N/A from the current AZN share price of $61.77.

What is AZN's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: AZN) Astrazeneca's current Earnings Per Share (EPS) is $1.44. On average, analysts forecast that AZN's EPS will be $2.64 for 2021, with the lowest EPS forecast at $2.57, and the highest EPS forecast at $2.68. On average, analysts forecast that AZN's EPS will be $3.54 for 2022, with the lowest EPS forecast at $3.24, and the highest EPS forecast at $3.82. In 2023, AZN's EPS is forecast to hit $4.15 (min: $3.80, max: $4.50).

What is AZN's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: AZN) forecast ROE is 38.75%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.